Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2015-05-31
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. A retrospective follow-up for MACE endpoints of patients who underwent a CCTA \>1 year ago as part of the Big PICTURE Trial, who meet the inclusion criteria of Big PICTURE 2.
2. A prospective observational registry of patients referred to undergo CCTA with a 1 and 2 year follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR
NCT05349084
Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography
NCT03292354
The CZT Dynamic Myocardial Perfusion Imaging
NCT02697760
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
NCT03253692
Incisive CT Clinica Trial Protocol
NCT05020262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
BIG PICTURE 2 (abbreviated as "BP2") will collect data on patients from a wide variety of imaging sites (inpatient, outpatient, in-clinic CT machine). While the majority of the sites are within the US, the data collection will not be limited to US-only sites. A sub study of BP2 will perform a remote short follow-up questionnaire of subjects who were in the original Big PICTURE study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CCTA
Subjects who underwent a CCTA
CCTA
CT of heart to assess coronary disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CCTA
CT of heart to assess coronary disease
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No prior CVD
* No hypertension
* No Diabetes
* Body mass index (BMI) \<35 kg/m2.
Exclusion Criteria
* Prior CVD
* Hypertension
* Body mass index (BMI) \>=30 kg/m2.
* Diabetes Mellitus Type 1 or 2
* Current or previous history of smoking
* Pregnancy
* Planned intervention or bypass surgery
* Known complex congenital heart disease
* Planned invasive angiography for reasons other than CAD
* Non-cardiac illness with life expectancy \< 2 years
* Inability to provide written informed consent
* Concomitant participation in another clinical trial in which subject is subject to investigational drug or device
* Pregnant women
* Allergy to iodinated contrast agent
* Serum creatinine \>1.5 mg/dl or GFR \<30 ml/min
* Baseline irregular heart rhythm
* Heart rate ≥100 beats per minute
* Systolic blood pressure ≤90 mm Hg
* Contraindications to β blockers or nitroglycerin Strategies for Recruitment and Retention
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MDDX LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MDDX
San Francisco, California, United States
FACTS
Hyderabad, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Big PICTURE 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.